Ana Obregón returns to television. The 68-year-old actress and presenter made her first film in 1979, more than 40 years ago, but she still feels the passion and strength to venture into new television projects.

After the death of her son Aless Lequio at just 27 years of age due to a type of cancer called Ewing’s sarcoma, Ana Obregón stopped her life, going through a very sad time in which she withdrew from the public sphere. Little by little, the actress was incorporated back into work and has appeared in some programs, in addition to presenting the Campanadas of TVE in recent years. In addition, her work with the foundation that she has created in honor of her son, the Aless Lequio Foundation, has given her the strength to carry on.

In the midst of the controversy over being a mother at 68 years of age through surrogacy in the United States, Ana Obregón has launched a new television project that will soon reach the homes of millions of viewers in our country.

The biologist returns to prime time thanks to Antena 3 and the successful program Mask Singer, where she will be part of the jury panel for the new edition that will try to discover who is hiding behind the masks. Despite the fact that there is still no official confirmation from Atresmedia about the program’s premiere date, we know that it will be launched in the coming weeks, since the chain has presented the first masks of this year, among which ‘Aceituna’ stands out. , ‘Little Mouse’ or ‘Pharaoh’.

Ana Obregón has occupied all the headlines on Wednesday after the magazine Hello! take the news of the year on the cover: the actress has traveled to the United States for her daughter, a girl she has had through a surrogate.

The news has aroused all kinds of opinions, since Obregón is 68 years old and many say that he will not be able to take care of the little girl. The debate on the morality and ethics of the practice of surrogacy, a way of being a mother with which many people do not agree and which is prohibited in our country, has also returned to the spotlight.